Dramatic Metabolic Response to Dual ICI With Chemotherapy in Low PD-L1 NSCLC Case

Despite low PD-L1 (Programmed Death-ligand 1) expression, this patient exhibited a dramatic positron emission tomography-computed tomography response to dual immune checkpoint inhibitors with chemotherapy. This case highlights the potential benefits of combination therapy beyond traditional PD-L1-based treatment selection.